CRBP (STOCKS)
Corbus Pharmaceuticals Holdings, Inc.
$7.580000
-0.340000 (-4.29%)
Prev close: $7.920000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Yuval Cohen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $134.58M
- Employees
- 28
- P/E (TTM)
- -1.44
- P/B (TTM)
- 1.08
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.90 | $-1.74 | -0.1586 | -9.11% |
|
Jun 2025 (Q2)
|
$-1.44 | $-1.54 | +0.1022 | +6.63% |
|
Mar 2025 (Q1)
|
$-1.39 | $-1.31 | -0.0844 | -6.46% |
|
Dec 2024 (Q4)
|
$-0.78 | $-1.29 | +0.5107 | +39.57% |
Financial Statements
| Revenues | $5.90M |
| Benefits Costs and Expenses | $73.41M |
| Costs And Expenses | $73.41M |
| Nonoperating Income/Loss | $8.44M |
| Operating Expenses | $75.95M |
| Depreciation and Amortization | $318.00K |
| Research and Development | $60.48M |
| Other Operating Expenses | $15.16M |
| Operating Income/Loss | -$75.95M |
| Income/Loss From Continuing Operations After Tax | -$67.51M |
| Income/Loss From Continuing Operations Before Tax | -$67.51M |
| Net Income/Loss | -$67.51M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$67.51M |
| Net Income/Loss Available To Common Stockholders, Basic | -$67.51M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.49 |
| Diluted Earnings Per Share | -$5.49 |
| Basic Average Shares | 37,174,265 |
| Diluted Average Shares | 37,174,265 |
| Assets | $109.51M |
| Current Assets | $107.57M |
| Noncurrent Assets | $1.94M |
| Fixed Assets | $201.00K |
| Other Non-current Assets | $1.74M |
| Liabilities | $17.37M |
| Current Liabilities | $17.06M |
| Accounts Payable | $2.74M |
| Wages | $2.41M |
| Other Current Liabilities | $11.91M |
| Noncurrent Liabilities | $307.00K |
| Equity | $92.15M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $92.15M |
| Liabilities And Equity | $109.51M |
| Net Cash Flow From Operating Activities | -$59.51M |
| Net Cash Flow From Operating Activities, Continuing | -$59.51M |
| Net Cash Flow From Investing Activities | $64.23M |
| Net Cash Flow From Investing Activities, Continuing | $64.23M |
| Net Cash Flow From Financing Activities | $2.84M |
| Net Cash Flow From Financing Activities, Continuing | $2.84M |
| Net Cash Flow | $7.56M |
| Net Cash Flow, Continuing | $7.56M |
| Comprehensive Income/Loss | -$67.72M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$67.72M |
| Other Comprehensive Income/Loss | -$210.00K |